ARDELYX, INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (3 lists). Names and jurisdictions are as filed.
- 2020-03-06: Subsidiary None.
- 2019-03-06: Subsidiary Ardelyx Cayman Islands (dissolved in 2018); Jurisdiction Cayman Islands.
- 2018-03-14: Subsidiary Ardelyx Cayman Islands (in liquidation); Jurisdiction Cayman Islands.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2020-03-06 | None | |
| 2019-03-06 | Ardelyx Cayman Islands (dissolved in 2018) | Cayman Islands |
| 2018-03-14 | Ardelyx Cayman Islands (in liquidation) | Cayman Islands |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |